Mexiprem® refers to heteroaromatic antioxidants. Has a wide range of pharmacological activity: increases the resistance of the body to stress, shows an anxiolytic effect, not accompanied by a muscle relaxant effect; has nootropic properties, prevents and reduces learning and memory disruptions arising from aging and exposure to variouspathogenic factors; has an anticonvulsant effect; exhibits antioxidant and antihypoxic properties; increases concentration and efficiency; alleviates the toxic effects of alcohol.
The drug improves the metabolism of brain tissues and their blood supply, improves microcirculation and rheological properties of blood, reduces the aggregation of platelets. Stabilizes the membrane structures of blood cells (erythrocytes and platelets). Has a hypolipidemic effect, reduces the content of total cholesterol and low-density lipoproteins.
The mechanism of action of Mexiprim® is due to its antioxidant and membrane-protective action. It inhibits lipid peroxidation, increases the activity of superoxide oxidase, increases the ratio of lipid-protein, reduces the viscosity of the membrane, increases its fluidity. Modulates the activity of membrane-bound enzymes (calcium-independent phosphodiesterase, adenylate cyclase, acetylcholinesterase), receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, helps preserve the structurally functional organization of biomembranes,transport of neurotransmitters and improvement of synaptic transmission. Mexiprim® increases the content of dopamine in the brain. It causes an increase in compensatory activation of aerobic glycolysis and a decrease in the degree of inhibition of oxidative processes in the Krebs cycle under conditions of hypoxia with an increase in the content of ATP and creatine phosphate, activation of the energy-synthesizing functions of mitochondria, and stabilization of cell membranes.